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ABC of palliative care
Constipation and diarrhoea
Marie Fallon, Bill O’Neill
Prevalence of constipation
Constipation can be defined as the passage of small hard faeces
infrequently and with difficulty. Constipation is more common
in patients with advanced cancer than in those with other
terminal diseases, and many of the associated symptoms may
mimic features of the underlying disease. About half of patients
admitted to specialist palliative care units report constipation,
but about 80% of patients will require laxatives.
Assessment of constipation
History
An accurate history is essential for effective management.
Inquiry should be made about the frequency and consistency of
stools, nausea, vomiting, abdominal pain, distention and
discomfort, mobility, diet, and any other symptoms. In patients
with a history of diarrhoea, care should be taken to distinguish
true diarrhoea from overflow due to faecal impaction.
Careful questioning about access to a toilet or commode is
important. Limited mobility may mean that using the toilet or
commode is avoided. Other issues, such as lack of privacy or the
need for nurses or carers to help with toileting, can exacerbate
constipation.
Examination
A constipated patient may have malodorous breath, or the smell
of faecal leakage may be obvious. Bacterial degradation of hard
stools can result in leakage, of which the patient has no
warning. General observation may reveal that a patient is in
pain, confused or disorientated, or unable to reach the toilet.
Abdominal distension, visible peristalsis, and borborygmi can
suggest obstruction.
Palpation may reveal an easily palpable colon with
indentable and mobile (and rarely tender) faecal masses. In
contrast, tumour masses are usually hard, not indentable, fixed,
and often tender. In constipation complicated by obstruction,
auscultation of the abdomen may reveal high pitched tinkling
bowel sounds, although the abdomen can also be silent.
Digital examination of the rectum or stoma is crucial if
constipation is suspected—this will immediately reveal hard
stools, tumour masses, or concomitant disease such as
haemorrhoids, an anal fissure, or perianal ulceration. The
rectum or stoma can be empty in constipation—hard or even
impacted stools can lie higher in the bowel.
Constipation may herald a spinal cord compression. If a
neurological deficit is suspected a full neurological examination
is essential, including assessment of sphincter tone and rectal
sensation. Referral, if appropriate, should be made as an
emergency.
Investigation
Occasionally, despite an accurate history and examination, the
diagnosis of constipation is still not clear. A plain x ray of the
abdomen can be useful. Large amounts of stools may appear as
clumps of rounded masses with entrapped gas and varying
degrees of dilated bowel. Rarely, toxic dilation of the colon may
be seen.
Constipation
Definition
x Infrequent hard stools
Associated symptoms
x Flatulence
x Bloating
x Abdominal pain
x Feeling of incomplete
evacuation
Symptoms of complications
x Anorexia
x Overflow diarrhoea
x Confusion
x Nausea and vomiting
x Urinary dysfunction
Assessment of constipation must include
establishing in what way the present
pattern of bowel movements is different
from the normal pattern and a physical
examination, including general
observation, abdominal palpation, and
rectal or stomal examination
Radiograph of constipated patient showing stool masses and trapped gas
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Causes of constipation
Knowledge of the underlying cause helps in both prophylaxis
and treatment. The most important of these are immobility,
poor fluid and dietary intake, and drugs, particularly opioids.
Opioid induced constipation
In patients with cancer and pain, the use of opioids is the
commonest cause of constipation, particularly in immobile
patients. Opioids cause constipation by maintaining or
increasing intestinal smooth muscle tone, by suppressing
forward peristalsis, by raising sphincter tone at the ileocaecal
valve and anal sphincter, and by reducing sensitivity to rectal
distension. This results in delayed passage of faeces through the
gut, with resultant increase in absorption of electrolytes and
water in the small intestine and colon.
Gastrointestinal obstruction
Sometimes, a combination of hard stools in the bowel and
intrinsic or extrinsic bowel tumour or pelvic tumour coexist,
causing gastrointestinal obstruction. With appropriate
management of the constipation, the obstructive symptoms may
resolve (intestinal obstruction has been covered in an earlier
article in this series).
Neurological problems
Bowel management is particularly troublesome and is a
common problem in patients with spinal cord compression or
cauda equina syndrome. A combination of immobility, loss of
rectal sensation, poor anal and colonic tone, and pain may
result in constipation with overflow and variable degrees of
abdominal distension, nausea, and vomiting.
A cauda equina lesion will abolish the anocolonic reflex, but
a higher spinal cord lesion leaves this reflex intact. In the latter
case, digital rectal stimulation or suppositories will stimulate
colonic contraction and aid evacuation of the colon, whereas in
the cauda equina syndrome the colon remains lax.
The aim in managing spinal cord compression or cauda
equina syndrome is to attain a “controlled continence.” This
means giving an individualised combination of oral laxatives
daily with suppositories or enemas every two to three days to
enable rectal evacuation. The intention is to avoid incontinence
in those patients with loss of rectal sensation.
Managing constipation
The management of constipation extends well beyond the use
of laxatives. Attention to other symptoms—especially pain and
advice on diet, fluid intake, mobility, and toileting—contributes
to an effective outcome.
The aim of laxative therapy is to achieve comfortable
defecation, rather than any particular frequency of evacuation.
Although most laxatives are not very palatable, oral laxatives
should be used whenever possible. The choice of laxative
depends on the nature of the stools, the cause of the
constipation, and acceptability to the patient. Laxatives can be
subdivided into three groups:
x Predominantly softening
x Predominantly peristalsis stimulating
x Combination of the two.
When choosing laxatives, a knowledge of the main
mechanism of action of laxatives is helpful. Many of the
softeners increase stool bulk and lead to reflex stimulation of
peristalsis, and, similarly, the peristalsis stimulators enhance
intestinal fluid secretion and therefore improve stool
consistency.
Causes of constipation
Caused by cancer
x Hypercalcaemia
x Intra›abdominal or pelvic
disease
x Spinal cord compression
x Cauda equina syndrome
x Depression
Associated with debility
x Weakness
x Inactivity or bed rest
x Poor nutrition
x Poor fluid intake
x Confusion
x Inability to reach the toilet
Caused by treatment
x Opioids
x Antiemetics—cyclizine,
ondansetron
x Anticholinergics—antispasmodics,
antidepressants, neuroleptics
x Aluminium salts
x Non›steroidal anti›inflammatory
drugs
Concurrent disorders
x Haemorrhoids
x Anal fissure
x Endocrine dysfunction
A distended rectum or colon can be a
potent cause of agitation and pain in a
dying patient. Evacuation of the rectum or
colon with suppositories alone or with an
enema can give complete relief of
agitation. The use of opioids to treat the
pain of constipation only makes the
constipation, and ultimately the pain,
worse and a vicious cycle ensues
Oral laxatives
Predominantly softening
Surfactants—Sodium docusate, poloxamer
Osmotic laxatives—Lactulose, sorbitol
Bulking agents—Ispaghula, methyl cellulose
Saline laxatives—Magnesium sulphate
Lubricants—Liquid paraffin
Predominantly peristalsis stimulating
Anthracenes—Senna, danthron
Polyphenolics—Bisacodyl, sodium picosulphate
Analgesia
(with or without various symptoms)
Abdominal pain
"Overflow diarrhoea"
"Overflow incontinence"
Urinary retention
Constipation
Vicious cycle of constipation associated with opioid
analgesia
Clinical review
1294 BMJ VOLUME 315 15 NOVEMBER 1997
Predominantly softening laxatives
Surfactant laxatives act as detergents, increasing water
penetration and hence softening the stools. Docusate also
promotes secretion of water, sodium, and chloride in the
jejunum and colon. Poloxamer and docusate have a latency of
action of one to three days. Docusate is often used alone as a
softener in intermittent bowel obstruction. It is also used in
combination with the peristalsis stimulator danthron (as
co›danthrusate). Poloxamer is marketed only in combination
with danthron (co›danthramer). Both co›danthrusate and
co›danthramer are effective laxatives for opioid induced
constipation.
Osmotic laxatives—The most popular in this group is
lactulose. Its latency of action is up to three days. It flushes the
small bowel and, with larger doses, tends to result in bloating
and colic. Flatulence and its sweet taste can cause problems with
compliance. Sorbitol is cheaper and less nauseating. Osmotic
laxatives should be accompanied by an increase in fluid intake.
Bulk forming agents are stool normalisers rather than true
laxatives. They are less helpful in cancer patients because of the
volume of water required, their unproved efficacy in severe
constipation, and the possibility of worsening an incipient
obstruction.
Saline laxatives—These, especially magnesium sulphate, can
produce an undesirably strong purgative action. Magnesium
hydroxide is also used in combination with liquid paraffin
(Milpar).
Lubricants—Liquid paraffin is now rarely used because of its
unpleasant taste and because, with long term use, it can cause
considerable irritation. Aspiration can result in a lipoidal
pneumonia.
Peristalsis stimulating laxatives
These drugs directly stimulate the myenteric plexus to induce
peristalsis and reduce net absorption of water and electrolytes
in the colon, making them particularly useful in opioid induced
constipation. Their latency of action is 6›12 hours. Any bowel
stimulant can cause abdominal colic and severe purgation. The
dose of stimulant should be titrated as with any potent drug and
consideration given to dose at each administration; colic may be
reduced by giving the total daily requirement in divided doses.
Senna can be used in combination with a softener such as
lactulose. Equal proportions of senna liquid and lactulose are
more potent than standard co›danthramer (danthron and
poloxamer), but seem less potent than co›danthramer forte.
Senna and danthron directly counteract the important
constipating effects of opioids and can be highly effective when
used with a stool softener. They are invaluable in colonic
inertias. Patients given danthron should be warned of the pink
or red discolouration of the urine, and the perianal area should
be watched for a danthron rash, particularly in incontinent
patients, who may require a barrier cream.
Rectal laxatives
Rectal laxatives are sometimes necessary but should never
accompany an inadequate prescription of an oral laxative. They
are necessary for treating faecal impaction and for conditions
such as spinal cord compression, when long term use may be
necessary. They should not, however, be part of the regular
treatment of every cancer patient with constipation. They are
undignified and inconvenient and may have a considerable
negative effect on quality of life.
Rectal laxatives are available as suppositories or enemas,
and their mode of action is similar to that of the equivalent oral
agent. Soft stools in a lax rectum can be evacuated by a
stimulant such as bisacodyl, and hard stools in the rectum can
Formulations of laxatives
Co›danthrusate
Combination of softener (docusate) and stimulant (danthron)
x Capsules—2 capsules at night up to 3 capsules four times daily
Co›danthramer
Combination of softener (poloxamer) and stimulant (danthron); available in
standard strength or forte (with 3 times as much danthron as standard but 5
times as much poloxamer)
x Capsules—2 capsules at night up to 3 capsules four times daily
x Liquid—15 ml at night up to 15 ml thrice daily
Lactulose*
Softener
x Liquid—15 ml twice daily (according to patient’s needs)
Senna*
Stimulant
x Tablets—2›4 tablets at night (if larger dose, split administration)
x Liquid
Sodium docusate
Softener (useful in intermittent bowel obstruction)
x Tablets—100›200 mg thrice daily
x Liquid—100›200 mg thrice daily
*Often used together
Questions to guide choice of rectal laxative
x Is the rectum or stoma full?
x Is the stool hard or soft?
x Is the rectum or stoma empty but the colon full?
x Are the rectum and colon both full?
x Does the patient have rectal sensation?
x Does the patient have normal anal tone?
x If a cord lesion is present what is the level?
Choices of rectal laxative
Bisacodyl suppository—Evacuates stools from rectum
or stoma; for colonic inertia
Glycerine suppository—Soften stools in rectum or
stoma
Phosphate enema—Evacuates stools from lower bowel
Arachis oil enema—Softens hard impacted stools
Access and ability to get to a lavatory may be more
important in constipation than supply of laxatives
Clinical review
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be softened with glycerine suppositories. A combination of a
bisacodyl suppository with a glycerine suppository is sometimes
helpful. In cases of colonic inertia, a bisacodyl suppository
placed in direct contact with the rectal mucosa may produce
rapid results.
Lubricant enemas such as arachis oil are normally given
overnight as retention enemas to soften very hard stools in the
rectum or higher up, before administration of a saline rectal
laxative such as sodium phosphate. In such severe cases the
enema should be administered high with a Foley catheter and
not just placed in the lower rectum, from where it will leak out
as it is administered. The catheter balloon can be inflated for
10 minutes to minimise immediate return of the enema.
For less severe impaction, a high phosphate enema may
suffice. Enemas may need to be repeated several times to clear
the bowel of hard impacted faeces; patients can then usually be
maintained with regular oral laxatives.
When rectal laxatives are required, an appropriate oral
laxative should be prescribed at the same time. Once
disimpaction occurs, the dose of oral laxative may need to be
titrated with the aim of reaching a maintenance dose that
prevents further faecal impaction.
Management of constipation in patients with stomas should
follow the principles outlined above, but it must be remembered
that no sphincter exists. Suppositories should be held in place
with a gloved finger, and enemas should be retained by inflating
a Foley catheter balloon for 10 minutes.
Diarrhoea
With the exception of patients with AIDS, diarrhoea is much
less common than constipation in patients with advanced
disease. Less than 10% of those with cancer admitted to hospital
or palliative care units have diarrhoea. Diarrhoea can be highly
debilitating in a patient with advanced disease because of loss of
fluid and electrolytes, anxiety about soiling, and the effort of
repeatedly going to the lavatory.
Causes
The commonest cause of diarrhoea in patients with advanced
disease is use of laxatives. Patients may use laxatives erratically;
some wait until they become constipated and then use high
doses of laxatives, with resultant rebound diarrhoea. Some
patients complain that their laxatives are too strong; adequate
explanation on the use of laxatives may solve the problem.
Among elderly patients admitted to hospital with
non›malignant disease, constipation with faecal impaction and
overflow accounts for over half the cases of diarrhoea. Such
patients require rectal laxatives together with a stool softener;
care is required with stimulant laxatives as they may cause colic.
Management
Consideration must be given to the underlying cause, but, with
the exception of the scenarios above, symptomatic relief is
generally achieved with non›specific antidiarrhoeal agents—
loperamide (up to 16 mg daily) or codeine (10›60 mg every
4 hours). Codeine may cause central effects such as drowsiness
or sedation, but this is rare with loperamide. In general, a single
drug should be used, and care should be taken to avoid
subtherapeutic doses of combinations of drugs.
Rarely, intractable diarrhoea may require a subcutaneous
infusion of octreotide; the usual indication is a high effluent
volume from a stoma. Obstructive rectal and pelvic lesions can
be managed by radiotherapy and chemotherapy, surgery, or, in
the case of rectal lesions, laser therapy. Palliative surgery may be
necessary for patients with a fistula.
Causes of diarrhoea in advanced disease
x Drugs
Laxatives
Antibiotics
Antacids
Chemotherapy (5›fluorouracil)
x Radiotherapy
x Intestinal obstruction (including
faecal impaction)
x Concurrent disease, such as
inflammatory bowel disease
x Diet
x Tumour
Colon or rectum
Pelvic
Pancreatic (islet cell)
Carcinoid
Fistula
x Malabsorption
Pancreatic carcinoma
Gastrectomy
Ileal resection
Colectomy
x Infection
Specific treatments for diarrhoea
x Cholestyramine
Radiotherapy induced diarrhoea
Chologenic diarrhoea
x Ranitidine (or other H2 antagonist)
Zollinger›Ellison syndrome
Fat malabsorption (with Pancreatin)
x Cyproheptadine
Carcinoid syndrome
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The ABC of palliative care is edited by Marie Fallon and Bill O’Neill
and will be published as a book in June 1998.
Radiograph showing megacolon secondary to rectal impaction
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